kidney cancer
Hollings researchers will develop AI-driven tools to better match cancer patients to marketed therapies and clinical trials.
UK Consortium Launches With Public-Private Funding to ID Immunotherapy Biomarkers
The Francis Crick Institute and the Royal Marsden Foundation Trust are spearheading the MANIFEST project with £21.9 million in government and industry funding.
NextPoint Therapeutics Nominates Third Clinical Program Targeting HHLA2/B7-H7
The firm is hoping to advance NPX372 for treating B7-H7-expressing solid tumors and is developing an assay to identify best responders.
Arsenal Biosciences Raises $325M in Series C Financing Round
The firm will use the funds to continue developing its pipeline of CAR T-cell therapies, scale up manufacturing capabilities, and explore novel T-cell therapies.
Allarity Therapeutics Facing Potential Legal Action for Violation of SEC Laws
The SEC warned of enforcement action regarding Allarity's disclosures about FDA interactions seeking approval for dovitinib and its companion diagnostic.
Jul 27, 2023